Health News Releases

January 30, 2019 11:55

Ensuring the Health and Safety of Global Aquaculture: House Wellness Foods’ Feed LP20® Boosts Commercial Nile Tilapia Production, Reduces Antibiotic Use

In the ongoing effort to battle world hunger and expand the production of healthy livestock, House Wellness Foods’ groundbreaking, immunobiotic-based Feed LP20® has once again produced conclusive rese

January 24, 2019 14:59

ACCUNIQ to Supply Body Composition Analyzer to World Gym

SELVAS Healthcare Inc. has signed a contract with World Gym International, LLC. to supply its body composition analyzer ACCUNIQ to the World Gym Franchisees. Under the contract, SELVAS Healthcare w

January 22, 2019 16:15

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s hea

January 22, 2019 13:50

ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.

ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under t

January 22, 2019 11:55

Metabolon Appoints Michael Rasche as President of International Business

Metabolon, the world leader in metabolomics, today announced that Michael Rasche joined the company as President of International Business. Michael will report to Rohan Hastie, Metabolon’s President a

January 18, 2019 11:05

Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer

Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small-molecule drugs to treat NASH and cancer, announced today the appo

January 11, 2019 09:00

Korean Health Food Distribution Brand Nature Food Distributes ‘Chong Kun Dang 6-year-old Red Ginseng Gold’ Abroad

Ewha Company said its food brand, Nature Food, will begin an international distribution of health food product, ‘Chong Kun Dang 6-year-old Red Ginseng Gold.’ Red ginseng has many medicinal effects

January 11, 2019 08:55

R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

The new Code of Practice of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) came into effect on 1 January 2019. The 2019 Code is marked by two important changes.

January 10, 2019 09:40

FotoFinder Systems: Artificial Intelligence Revolutionizes Skin Cancer Detection

“Artificial Intelligence” (AI) is currently on everyone's lips. Experts say companies need to focus on three aspects of AI to play a leading role in the topic: latest programming insights, importance

January 10, 2019 09:10

Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.

ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely availab

January 09, 2019 19:10

Takeda Completes Acquisition of Shire, Becoming a Global, Values-Based, R&D-Driven Biopharmaceutical Leader

Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharma

January 09, 2019 09:15

Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours

Cambridge Epigenetix Ltd, a pioneer in the development and application of epigenetic technologies, today announces its discovery and development programme for a test to detect colorectal and other can

January 08, 2019 18:00

ResMed Completes $225 Million Acquisition of Propeller Health

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Prop

January 08, 2019 13:25

Factory CRO and Boston Biomedical Associates Announce Merger

Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston Biomedical Associates (BBA) a premier full-service Medic

January 07, 2019 17:10

Solasia Initiates Phase III Program for PledOx® in Japan

Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) announced the initiation of Phase III clinical trial for PledOx® in Japan. In No

January 07, 2019 10:15

GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment

GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be develop

January 07, 2019 10:10

Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna

Boehringer Ingelheim and Dicerna Pharmaceuticals (NASDAQ: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that Boehringer Ingelheim has exercised an

January 07, 2019 10:05

Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the Acquisition of Shire plc

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) notes Shire plc’s (“Shire”) announcement that the Royal Court of Jersey (the “Jersey Court”) has today sanctioned the scheme of arr

January 04, 2019 18:00

Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders

Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) today announced two new global agreements to investigate, develop and commercialize novel small molecules targeting t

January 04, 2019 17:05

Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus for the company. Through these collabo

January 04, 2019 10:15

Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies

Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running re

December 28, 2018 15:30

22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, today submitted a Modified Risk Tobacco Product (MRTP) ap

December 24, 2018 11:45

Henry Schein and Vets First Choice Announce New Name of the Planned New Company: Covetrus

Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced that the new standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and

December 20, 2018 15:15

Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

December 18, 2018 18:20

Fuji Pharma Invests in Alvotech for US$50 Million

Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2% stake in the business for approximately US$50 million. Alvotech and Fuji Pharma recently announce

News by Region

News by Industry